Medicament Formulation Private Limited
About Medicament Formulation Private Limited
Data last updated:
Medicament Formulation Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 17 March 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21009DL2023PTC411191.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ranjana Devi and Ram Binay Jha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No – 88 Block – Rz T/F/B/Side, Sukhi Ram Park – Uttam Nagar New Delhi Near Matiala Road, Delhi, India – 110059.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.86 Lakh. For the same year it recorded a net profit of ₹1.25 Lakh (net margin 6%) and EBITDA of ₹1.7 Lakh (EBITDA margin 8.2%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH No – 88 Block – Rz T/F/B/Side, Sukhi Ram Park – Uttam Nagar New Delhi Near Matiala Road, Delhi, India – 110059
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medicament Formulation Private Limited
The main business activity of Medicament Formulation is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medicament Formulation Private Limited FY 2025 filings available
Medicament Formulation Private Limited reported revenue of ₹20.86 Lakh for FY 2025.
Financial Statement Summary of Medicament Formulation Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹1.7 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.25 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Medicament Formulation Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 8.2% | •••• | •••• |
| Net Profit Margin | 6% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medicament Formulation are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Medicament Formulation Private Limited
Medicament Formulation Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sepkind Pharma Private Limited | ₹22.18 Lakh (FY 2024) | •••• | •••• | •••• | Panchkula, Haryana, India | |
| Xlinar Pharmaceuticals Private Limited | ₹22.18 Lakh (FY 2025) | •••• | •••• | •••• | Murshidabad, West Bengal, India | |
| Mysa Life Science Private Limited | ₹21.87 Lakh (FY 2025) | •••• | •••• | 650.0% | •••• | Premnagar, Uttar Pradesh, India |
| Zeokind India Private Limited | ₹21.54 Lakh (FY 2024) | •••• | •••• | •••• | Faridabad, Haryana, India | |
| Fealty Lifesciences Private Limited | ₹21.29 Lakh (FY 2025) | •••• | •••• | -12.0% | •••• | Aurangabad, Maharashtra, India |
| Medicament Formulation Private Limited this company | ₹20.86 Lakh (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Elevix Pharmaceutical Private Limited | ₹20.46 Lakh (FY 2024) | •••• | •••• | -13.0% | •••• | Aurangabad, Maharashtra, India |
| Maashree Ayurved Private Limited | ₹20.33 Lakh (FY 2024) | •••• | •••• | •••• | Thanesar, Haryana, India | |
| Ayush Herbal & Healthcare Private Limited | ₹19.83 Lakh (FY 2025) | •••• | •••• | 116.0% | •••• | Nahan, Himachal Pradesh, India |
| Point Bio Healthcare Private Limited | ₹19.82 Lakh (FY 2024) | •••• | •••• | -49.0% | •••• | Bhopal, Madhya Pradesh, India |
| Joyglad Healthcare Private Limited | ₹19.67 Lakh (FY 2025) | •••• | •••• | •••• | Bishrakh, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Medicament Formulation by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Medicament Formulation Private Limited
Medicament Formulation has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ranjana Devi | Director | 17 Mar 2023 | 3 Years 6 Months | Current |
| Ram Binay Jha | Director | 17 Mar 2023 | 3 Years 6 Months | Current |
| Sushil Kumar | Director | 17 Mar 2023 | 3 Years 6 Months | Current |
Charges & Borrowings of Medicament Formulation Private Limited
Medicament Formulation Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Medicament Formulation Private Limited
Employment history and EPFO contributions of people linked to Medicament Formulation.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medicament Formulation Private Limited
Medicament Formulation Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Ram Binay Jha was appointed as Director on 17 Mar 2023.
Credit Ratings, Litigation & Regulatory Alerts for Medicament Formulation Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medicament Formulation Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medicament Formulation Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medicament Formulation Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medicament Formulation Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medicament Formulation Private Limited
Medicament Formulation is an active private limited company based in New Delhi, Delhi, India. The company works in paper and paper products, within the paper industry. It was incorporated on 17 March 2023 (3+ years old) and is registered under CIN U21009DL2023PTC411191.
Medicament Formulation reported revenue of ₹20.86 Lakh for FY 2025.
Medicament Formulation has 3 current directors:
- Ranjana Devi - Director
- Ram Binay Jha - Director
- Sushil Kumar - Director
Medicament Formulation reported a net profit of ₹1.25 Lakh (net margin 6%) and EBITDA of ₹1.7 Lakh (EBITDA margin 8.2%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Medicament Formulation is U21009DL2023PTC411191. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medicament Formulation was incorporated on 17 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medicament Formulation by revenue are Sepkind Pharma Private Limited, Xlinar Pharmaceuticals Private Limited, Mysa Life Science Private Limited, Zeokind India Private Limited, Fealty Lifesciences Private Limited and 5 more, all in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations).
Ram Binay Jha was appointed as Director on 17 Mar 2023. Ranjana Devi was appointed as Director on 17 Mar 2023. Sushil Kumar was appointed as Director on 17 Mar 2023.
The registered office of Medicament Formulation is at H No – 88 Block – Rz TFBSide, Sukhi Ram Park – Uttam Nagar New Delhi Near Matiala Road, Delhi, India – 110059.
Medicament Formulation has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Medicament Formulation operates in the paper industry, in the paper and paper products segment.